Understanding of latent tuberculosis, its treatment and treatment side effects in immigrant and refugee patients

BMC Res Notes. 2013 Aug 29:6:342. doi: 10.1186/1756-0500-6-342.

Abstract

Background: Isoniazid treatment of latent tuberculosis infection (LTBI) is commonly prescribed in refugees and immigrants. We aimed to assess understanding of information provided about LTBI, its treatment and potential side effects.

Methods: A questionnaire was administered in clinics at a tertiary hospital. Total Knowledge (TKS) and Total Side Effect Scores (TSES) were derived. Logistic regression analyses were employed to correlate socio-demographic factors with knowledge.

Results: Fifty-two participants were recruited, 20 at isoniazid commencement and 32 already on isoniazid. The average TKS were 5.04/9 and 6.23/9 respectively and were significantly associated with interpreter use. Approximately half did not know how tuberculosis was transmitted. The average TSES were 5.0/7 and 3.5/7 respectively, but were not influenced by socio-demographic factors.

Conclusions: There was suboptimal knowledge about LTBI. Improvements in health messages delivered via interpreters and additional methods of distributing information need to be developed for this patient population.

MeSH terms

  • Adolescent
  • Adult
  • Antitubercular Agents / administration & dosage
  • Antitubercular Agents / adverse effects*
  • Australia
  • Communication Barriers*
  • Emigrants and Immigrants
  • Female
  • Health Knowledge, Attitudes, Practice*
  • Humans
  • Isoniazid / administration & dosage
  • Isoniazid / adverse effects*
  • Latent Tuberculosis / drug therapy
  • Latent Tuberculosis / psychology*
  • Male
  • Patient Compliance
  • Refugees
  • Surveys and Questionnaires

Substances

  • Antitubercular Agents
  • Isoniazid